EarningsQ4 2023 Earnings Report

Mirum Pharmaceuticals (MIRM) Q4 2023 Earnings Report

0 Followers

MX:MIRM Q4 2023 EPS Results

Actual EPS-$11.60

Consensus EPS-$4.42

Beat/MissMissed by -$7.18

One Year Ago EPS-$18.23

Actual Revenue$1.28B

Expected Revenue$1.25B

Beat/MissBeat by +$31.06M

YoY Revenue Growth+149.24%

QuarterQ4 2023

Date02/28/2024

TimeAfter Close

Conference CallWednesday, February 28, 2024

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-9.00 / -	0.921	―
Aug 05, 2026	2026 (Q2)	-13.68 / -19.52	-2.21	-783.33% (-17.31)
May 06, 2026	2026 (Q1)	-6.72 / -247.30	-5.524	-4376.67% (-241.78)
Feb 25, 2026	2025 (Q4)	1.03 / -1.84	-9.023	79.59% (+7.18)
Nov 04, 2025	2025 (Q3)	-2.58 / 0.92	-5.524	116.67% (+6.44)
Aug 06, 2025	2025 (Q2)	-6.00 / -2.21	-9.575	76.92% (+7.37)
May 07, 2025	2025 (Q1)	-6.08 / -5.52	-9.944	44.44% (+4.42)
Feb 26, 2025	2024 (Q4)	-4.75 / -9.02	-11.601	22.22% (+2.58)
Nov 12, 2024	2024 (Q3)	-8.27 / -5.52	-10.496	47.37% (+4.97)
Aug 07, 2024	2024 (Q2)	-8.69 / -9.58	-35.723	73.20% (+26.15)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed